Soleno Therapeutics Inc (SLNO)
72.00 x 4 72.25 x 18
Post-market by (Cboe BZX)
71.99 +4.60 (+6.83%) 03/28/25 [NASDAQ]
72.00 x 4 72.25 x 18
Post-market 72.00 +0.01 (+0.01%) 19:43 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 87,928 | 48,413 | 57,024 | 42,847 | 169,681 |
Marketable Securities | 203,509 | 208,363 | 209,099 | 106,780 | N/A |
TOTAL | $293,889 | $258,199 | $267,502 | $151,223 | $171,358 |
Non-Current Assets | |||||
PPE Net | 186 | 196 | 19 | 27 | 12 |
Investments And Advances | 27,211 | 27,945 | 28,482 | 8,821 | 0 |
Intangibles | 6,805 | 7,291 | 7,777 | 8,263 | 8,749 |
Other Non-Current Assets | 2,881 | 3,075 | 351 | 503 | 572 |
TOTAL | $37,083 | $38,507 | $36,629 | $17,614 | $9,333 |
Total Assets | $330,972 | $296,706 | $304,131 | $168,837 | $180,691 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 8,882 | 6,243 | 3,716 | 8,022 | 3,149 |
Accrued Expenses | 6,602 | 5,170 | 4,012 | 3,621 | 6,528 |
Other current liabilities | 2,737 | 3,101 | 1,126 | 1,511 | 1,555 |
TOTAL | $18,747 | $14,962 | $9,150 | $13,464 | $11,505 |
Non-Current Liabilities | |||||
aiOther Non-Current Liabilities | 67,112 | 17,045 | 14,224 | 11,987 | 11,679 |
TOTAL | $67,112 | $17,045 | $14,224 | $11,987 | $11,679 |
Total Liabilities | $85,859 | $32,007 | $23,374 | $25,451 | $23,184 |
Shareholders' Equity | |||||
Shares Outstanding, K | 45,857 | 43,117 | 38,872 | 33,411 | 32,461 |
Common Shares | 46 | 41 | 38 | 33 | 32 |
Retained earnings | -452,260 | -396,278 | -319,662 | -297,808 | -276,410 |
Other shareholders' equity | 361 | 895 | -153 | -106 | 0 |
TOTAL | $245,113 | $264,699 | $280,757 | $143,386 | $157,507 |
Total Liabilities And Equity | $330,972 | $296,706 | $304,131 | $168,837 | $180,691 |